chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hives type rash on face, lips, neck, chest, forearms, under arms, left side of stomach, left outside thigh, and bottom front right leg.; hives type rash on face, lips, neck, chest, forearms, under arms, left side of stomach, left outside thigh, and bottom front right leg.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Nov2021 (Lot number: 330308D) at the age of 68 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Trigeminal neuralgia" (unspecified if ongoing); "Arthritis" (unspecified if ongoing); "Osteoporosis" (unspecified if ongoing); "Mitral valve prolapse" (unspecified if ongoing); "Vitamin D Deficiency" (unspecified if ongoing). Concomitant medication(s) included: PROLIA, administration date 17Nov2021. Vaccination history included: Bnt162b2 (previous dose product=COVID 19,, previous dose brand=Pfizer, previous dose brand unknown=False, previous dose lot number=EN6202, previous dose lot unknown=False, previous dose administration date=01Mar2021 , previous dose dose number=2, previous dose vaccine location=Left arm), administration date: 01Mar2021, when the patient was 68 years old, for COVID-19 immunization; Bnt162b2 (Previous dose product=COVID 19, Previous dose brand=Pfizer, Previous dose brand unknown=False, Previous dose lot number=EL8982, Previous dose lot unknown=False, previous dose administration date=08Feb2021, previous dose dose number=1, previous dose vaccine location=Left leg), administration date: 08Feb2021, when the patient was 68 years old, for COVID-19 immunization. The following information was reported: URTICARIA (non-serious), RASH (non-serious) all with onset 30Nov2021, outcome "not recovered" and all described as "hives type rash on face, lips, neck, chest, forearms, under arms, left side of stomach, left outside thigh, and bottom front right leg.". The event "hives type rash on face, lips, neck, chest, forearms, under arms, left side of stomach, left outside thigh, and bottom front right leg." and "hives type rash on face, lips, neck, chest, forearms, under arms, left side of stomach, left outside thigh, and bottom front right leg." was evaluated at the physician office visit. Therapeutic measures were taken as a result of urticaria, rash.  Additional information:The patient took other vaccine in fourweeks and other medications in twoweeks and known allergies :Yes and the patient was not tested positive for COVID-19 before and after the vaccination.  Follow-up attempts are completed. No further information is expected.
Patient was observed post Covid-19 immunization for 15 minutes after her vaccination at 11:20am. Reports to us at 1:38pm after experiencing tachycardia at 1:30pm. No complaints of SOB, rash or throat swelling. History of eating disorder and soda 2 hrs prior to episode. Initial V/S 122/67, 144, 20, O2 sat 98%.  PE: Skin with no rash. Alert, cooperative and calm appearing. Lungs sounds clear A&P, heart rate regular.   Actions taken: Repeat V/S @155pm- P-124, B/P 121/69. EMS called and she will be further evaluated in ER.      Medications administered: No medication administered.   Disposition: Patient evaluated and transferred to the hospital for further evaluation and care. Time of transport: 1:55pm.
Gave Pediarix left leg instead of Dtap, also gave seperate dose of IPV right arm.
Increase BP, client verbalized itchy throat, numbiness/tingling to right and left arm.
Slight stiffness after injection; This is a spontaneous report from a Pfizer-sponsored Program Pfizer from a contact-able consumer or other non hcp. Upon Fu date (08Mar2021) case was upgraded to valid. A 72-year-old female patient received second dose received from BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6193), via intramuscular route, administered in left arm on 21Feb2021 as dose 2, single for COVID-19 immunisation. Medical history included asthma from 01Aug1974 and ongoing no hospitalization or ER ever, cardiomyopathy Non-Ischemic Cardiomyopathy from 30May2008 and ongoing with angiogram- no blockage, atrial fibrillation from 04Oct2014 and ongoing (2 weeks after my husband died and stress related). The patient's concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EM9810), via intramuscular route, administered in right arm on 06Feb2021 at 14:00 as dose 1, single for COVID-19 immunisation. On an unspecified date on Mar2021, the patient experienced slight stiffness after injection 02. No noticeable rise in temperature, aches, pains, tiredness or headache after both shots (Last one almost 48 hours ago). The outcome of the event unknown.  No follow-up attempts are possible. No further information is expected.
Patient immediately after getting the vaccine stated his arm was very sore.  After he sat down to be observed for 15 minutes he started feeling like he was going to vomit and/or lose consciousness.  He started sweating profusely and stated that both arms felt tingly and numb.  I immediately gave him juice and applied a cold pack to his back. After a couple of mins he stated that he was feeling a little better.  We called the ambulance and they arrived and took over his care.  He was not transported to the hospital
Fever, redness, swelling at injection site, hard lump. 24 hours later cellulitis formed.
1 Week after the vaccine the patient developed Ataxia, Diplopia and bilateral hand numbness.  Diagnosis - Miller Fisher variant of Guillan Barre.
Pt with reaction to vaccines given at Dr. office on 8/2. Pt was given Proquad in Left Arm and Kinrix in right arm vaccines on 8/2/2019 Mother noted redness to right deltoid yesterday 8/3/2019 with increased redness/swelling today, Warm to the touch. Pt mother stated that on Saturday it half dollar size. Mother used Benadryl and Ice and bu Sunday tripled in size went to urgent care. They gave Pt steroids  and Benadryl and today 8/5/19 spot has vaccine sight has doubled in size. Nurse for Dr. has contacted Pt mother this morning. Pt mother states that urgent care circled the site and it has doubled in size and she is on her way to Medical Center Emergency Room to have Pt seen.
Fever, chills, nausea, headache, fatigue and significant muscle soreness in arm that received injection until 48 hours after the vaccine was administered. Took acetaminophen regularly until symptoms subsided.
49 y.o. female presented to the clinic for follow-up of recent Prevnar 20 vaccination which was given 10/19/2023 on her right deltoid muscle, patient report associated redness, itching and slight warm to touch for the past 1 week. No associated fever, chills or night sweats. Medications include celecoxib (CELEBREX) 200mg capsule and triamcinolone (KENALOG) 0.5% cream. Patient contacted on 11/2/2023 to follow-up on vaccine reaction. Patient stated that she is still experiencing pain to right arm and she developed fever on 10/27/23 that lasted until 10/29/2023. Patient remained fever free since 10/29/2023. Patient managed fever with tylenol (unknown dose).
Started with headache and fever. Fever spike from 99.4 to 101.3 in 1.5 hours. Vomited one time. Chills, sweating, hot-then-cold, and terrible body aches persisted for the next 24 hours.
SYNCOPE; RAINBOW VISION; COUPLE OF NEAR SYNCOPE EPISODES; VERY FATIGUED; HEADACHES; This spontaneous report received from a physician concerned a 32 year old female of an unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypohidrosis, and occasional light headed bouts, and other pre-existing medical conditions included: The patient was a Pilot, very active and runs 2-3 miles a day.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported, 01 total administered on MAR-2022 for covid-19 prophylaxis. The batch number was not reported and has been requested. Age at time of vaccination 4 decade old. No concomitant medications were reported.  On an unspecified date, the patient experienced couple of near syncope episode has not had a tilt test or anything in the past. The patient had a couple of frank syncopal episodes over the last several months, one with a documented blood pressure of 60. No injuries. The patient also experienced fatigue and headaches. The patient did not have that problem at all. One of the things the patient was complaining about was rainbow vision, that periodically comes and goes. 3 weeks ago, the patient had an episode (of syncope) out of nowhere and went for cardiovascular evaluation. The physician exercised the patient for 20 minutes, no chest pain, and had an essentially normal electrocardiogram. At the time of this report the reporter thought patient might have some underlying autonomic dysregulation that tripped the patient over into becoming more dysregulated in syncope. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the syncope, rainbow vision, very fatigued, headaches and couple of near syncope episodes was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20230144279-Syncope. The event has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the Causality is considered indeterminate. The company causality is considered unassessable.
This spontaneous report was received from a Licensed Practical Nurse concerning 2 patients of unknown age. On 12-MAR-2014, the patients received the 1st dose of RECOMBIVAX HB (lot number and other details unspecified), the 2nd dose of RECOMBIVAX HB on 24-APR-2014 and the 3rd dose of RECOMBIVAX HB on 30-MAY-2014. No concomitant therapy was reported. It was reported that, "the spacing between the 2nd and 3rd dose was too close". However, no adverse effects were reported. The action taken was assessed as not applicable. The outcome of event was not reported. The causality was assessed as not related to RECOMBIVAX HB. This is one of two reports received from the same reporter. Additional information has been requested.
Pt presented for reading of TB skin test on Wed 3/13/06. Mother states she noticed redness and swelling rt deltoid area 3/13/06 at 9:00 am. States she thought child was bitten by ants and cleaned area with antimicrobial hand gel. Redness and swelling 34 mm X 31 mm rt deltoid. Site hot to touch. No difficulty with movement of arm. No c/o by child. Instructed mother to administer Benedryl oral and/or topical and tylenol for discomfort. Also instructed may apply cool compress. Advise if swelling worsens or child has any s/s wheezing or difficulty breathing take child to ER.
severe pain down her both legs and the pain has not gone away; she also had back pain but it's a little bit better; she had nerve pain; I have the usual fever and you know feeling like I had the flu on Sunday the day after I had the flu on Sunday the day after I had the second vaccine.; I have the usual fever and you know feeling like I had the flu on Sunday the day after I had the flu on Sunday the day after I had the second vaccine.; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported), via an unspecified route of administration on 17Apr2021 (at the age of 61-year-old) as 2nd dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (lot no.: EN6204) on 27Mar2021 (at the age of 61-year-old) as single dose for COVID-19 immunization and she experienced a slight pain (minimal) down in both of her legs, pain from the vaccine, nerve pain and could barely walk. Then she received the second dose on 17Apr2021 and the next day (18Apr2021), she started experiencing a severe pain down her both legs and the pain has not gone away, she also had back pain but it's a little bit better, during the call she mentioned that she didn't have muscle or joint pain, that she had nerve pain. She has gone to many doctors, her life is affected negatively, she said that they should care people better. She would like to know why she is experiencing this pain. The patient also had the usual fever and flu on Sunday (18Apr2021) after she had the second vaccine. Therapeutic measures were taken as a result of the events which included Advil and Tylenol. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
I had a severe sinus infection, ear infection; bronchitis. It's been since June 7th and I'm on the 2nd round of prednisone. I saw an ENT this past Wednesday. On the 2nd round of antibiotics.
pt recv ax 12MAR98 & 4 days p/vax 16MAR98 pt had severe chills & cold clammy sweat w/listlessness & fatigue lasting through the day;also pain in opposite shoulder from shot site w/numbness going down to fingertips;seems to be subsiding;
Patient develoved 2 raised lumps on arm around injection sites. They were hot to touch but after 3 days seemed to be going away. One shot was given in rear deltoid muscle and the other was almost on back of patient's arm.
hair loss/eyebrows, cervical lymph node swelling, general itching, weakness Narrative: Vaccinated 3/4/2021, onset of hair loss 3/13/2021, lymph nodes 3/9/2021
Pt developed a fever up to 103.5F reported at home on 8/1/01. She had erythematous papular lesions appear 1st on trunk and then on face on 8/3/01. She was seen that day at ER. She was dx'd with viral exanthem. Seen today, 8/6/01, afebrile. Rash continues.
Missed period, currently 10 days late.  This is extraordinarily rare for me (patient) as my menstrual cycle has been like clockwork for 10 years and I use an app to track my menstrual cycles in detail, which I?ve used for several years with precision.
PATIENT RECEIVED THE WRONG VACCINE (PREVNAR 13) INSTEAD OF FLUARIX. PATIENT STATED THAT SHE ALREADY RECEIVED THE PREVNAR 13 IN THE PAST.
This spontaneous report as received from a licensed practical nurse refers to a multiple unspecified patients of unknown age and gender. No information on patients' medical history, concurrent conditions or concomitant medications was provided. On an unspecified dates in July 2015, the patients were vaccinated with improperly stored doses of MMR II injection (dose, lot# and expiration date were not provided). No adverse effects were reported. Additional information has been requested.
Fussiness and fever starting the day before, 3/28-19: 101.6, 102.2 temp earlier in the day. 101.5 in office 3-29-19 at 445pm after dose of Ibuprofen at 2pm per mom.
immediately p/admineresting the MMR/DT/OPV vax pt became very limp & began to slide off the chair; pt was held up by nurse; would not respond to verbal command; then became very rigid & made a gutteral sound; appeared disoriented; drowsy;
1/4/10 Client Dx from ortho Dr with Parsonage Turner Syndrome to his right arm. Interviewed client on 1/5/09 states arm was sore before injection and became progressively worse 1/7/10 went to clinic for Tx. Right arm became unable to use was painful.
Nurse accidently administered adult dose of VAQTA to unspecified child; This spontaneous report was received from a physician and refers to a child patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On 05-APR-2019, a nurse accidently vaccinated the patient with an adult dose of hepatitis a vaccine, inactivated(VAQTA) lot # R012739, 1 milliliter once, intramuscular, expiration date 09-AUG-2019, for prophylaxis.
Patient received booster dose 10/05/2022 and product expired 9/30/22
she presented to the clinic with redness and swelling in left arm. swelling extended down into elbow, red and warm to touch. dr fears ordered bactrim bid
(1400) Patient received PCV23 vaccine at around 10 AM in clinic. About 4 hr. later developed fever and was given TYLENOL. Remained febrile, so received 2nd dose of TYLENOL at 18:00. Around 19:00, increased WOB and received alb neb. Around that time, dad found that she was apneic, and was given CPR at home, and EMS arrived and transferred to hosp. where she was admitted, and discharged on 1/17/18. Found to have positive RSV type B and Rhinovirus on VRP testing. Mother felt like this is unusual for her previous resp time infections and want to report. Description of reaction as attached/written in front page. Mother concerned that the event might be related to the PNEUMOVAX vaccine that was given. Personally, I think it is less likely a vaccine allergy is most likely from her respiratory illness that led to increased work of breathing, hypoxemia and apnea. She was found to have RSV infection during hospitalization. She was a complex medical problem with frequent respiratory illness, critical hypoventilation, Beckwith-Wiedemann Syndrome, chromosome 2 deletion, bronchopulmonary dysplasia tracheostomy. This is reported per the mother's request as she was concerned that patient's clinical course of illness was more rapid and severe than her previous respiratory illnesses. MD, 2-14-2018.
After the vaccine, I got Covid arm with my left upper arm very red, hard to the touch and painful for several days. Then on May 5, I woke up with Bell's Palsy and was admitted to the E.R. as we were not sure what was happening.  I had Bell's Palsy for at least 6 weeks and am still experiencing eye issues from it. I believe the shot was what pre-empted the Bells Palsy.
This spontaneous report was received from a registered pharmacist concerning patients of unknown age and gender. On an unknown date, the patients were vaccinated with a dose of ZOSTAVAX (lot number, expiry date and dose unspecified), subcutaneously. No concomitant therapy was reported. The pharmacist noticed an increased incidence of injection site redness and swelling after the administration of ZOSTAVAX (date unspecified). At the time of the report, the pharmacist was unable to provide the exact number of identities of patients involved. The patients sought medical attention (notified pharmacist). It was unspecified if any treatment was given or if any lab tests were performed. On an unknown date, patients were recovered from injection site redness and swelling. The relatedness for injection site redness and swelling was unknown for ZOSTAVAX. Additional information has been requested.
Vaccine triggered my asthma. My asthma had been under control for the past 10 years. After the vaccine, my asthma came back and had to be on steroids for the following 3 months.
numbness in right side of lips, top/tip of tongue is numb; itching and warmth on ride side of face and ear; itching and warmth on ride side of face and ear; itching and warmth on ride side of face and ear; light headed; Headache; This is a spontaneous report from a contactable consumer (patient). A 34-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm right on 03Mar2021 12:45 as dose 1, single for covid-19 immunisation at Public Health Clinic. Medical history included severe asthma from an unknown date and unknown if ongoing, known allergies of penicillin and codeine from an unknown date and unknown if ongoing. Concomitant medication(s) included budesonide, formoterol fumarate (SYMBICORT); tiotropium bromide (SPIRIVA); salbutamol sulfate (VENTOLIN ACCUHALER); fluticasone propionate (FLOVENT); clarithromycin (CLARITIN) taken for an unspecified indication, start and stop date were not reported. The patient previously took penicillin and codeine and had known allergies to both. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 03Mar2021 13:30 the patient experienced numbness in right side of lips, top/tip of tongue is numb, itching and warmth on ride side of face, headache, lightheaded. No treatment was taken for all events. The outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient has breastfed infant since receipt of primary series, unknown if pregnant at time of receipt of first dose; Patient has breastfed infant since receipt of primary series, unknown if pregnant at time of receipt of first dose; Notified patient tested positive for COVID-19 on 25Jan2022; Notified patient tested positive for COVID-19 on 25Jan2022; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 31 year-old female patient (unknown if pregnant) received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single, administration date Mar2021 (Batch/Lot number: unknown) as dose 2, single and administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 25Jan2022, outcome "unknown" and all described as "Notified patient tested positive for COVID-19 on 25Jan2022"; OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious), outcome "unknown" and all described as "Patient has breastfed infant since receipt of primary series, unknown if pregnant at time of receipt of first dose". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (25Jan2022) positive. Therapeutic measures were not taken as a result of drug ineffective, covid-19.  Clinical course: Patient did not test COVID prior vaccination and tested positive post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200145127 Baby case
severe tinnitus; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (severe tinnitus) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (severe tinnitus). At the time of the report, TINNITUS (severe tinnitus) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment information was reported.   This case was linked to MOD21-087878, MOD21-082910 (E2B Linked Report).; Sender's Comments:  MOD21-087878: MOD21-082910: